glp-1 news 2025 october 16 In 2026, it feels like everyone is taking a GLP-1—or at least thinking about it. But experts worry that the explosion of demand (and prescribers trying to meet said demand) might impact How the rise of GLP-1

This Noom vs Weight Watchers article will help you confidently select the weight loss program that best fits your lifestyle, preferences, and goals to achieve sustainable results

GLP-1s may also reduce the risk of Alzheimers, the most common dementia affecting around 7 million Americans

University of Mississippi researchers are examining why, and where that leaves patients

Ishy PL, Fagerlund B, Broberg BV, Bak N, Knop FK, Glenthj BY, et al

Bilchick said the field is increasingly recognizing the importance of combining advanced procedures with therapies that target the underlying metabolic and inflammatory contributors to arrhythmias